Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blood-aqueous Barrier Integrity in Eyes Undergoing Intravitreal Bevacizumab Therapy to Treat Neovascular Age-related Macular Degeneration

NCT03744806 is registered in ClinicalTrials.gov with Medical University of Lublin as lead sponsor.

NCT NCT03744806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03744806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blood-aqueous Barrier Integrity in Eyes Undergoing Intravitreal Bevacizumab Therapy to Treat Neovascular Age-related Macular Degeneration
Lead sponsor
Medical University of Lublin
Phase
Observational
Overall status
Completed
Start date
January 31, 2015
Completion date
August 31, 2018
Enrollment
48 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

exudative age-related macular degeneration